Resolvin D1 Modulates the Inflammatory Processes of Human Periodontal Ligament Cells via NF-κB and MAPK Signaling Pathways
Open Access
- 10 December 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 3038
Abstract
Objectives: Periodontitis is a multifactorial inflammatory disease initiated by pathogenic bacteria, such as Porphyromonas gingivalis. Resolvin D1 (RvD1) plays a pivotal role in inflammation resolution. This study aimed to identify the mechanism of the regulatory effects of RvD1 on the inflammatory response of human periodontal ligament cells (hPDLCs). Methods: To investigate the mechanism of RvD1’s impact on the hPDLCs, RNA-sequencing (RNA-seq) was used and differentially expressed genes (DEGs) were identified. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to assess the signaling pathways in which NF-κB and MAPK were determined to play a significant role. Alterations in NF-κB and MAPK pathways were verified by immunofluorescence (IF), quantitative real-time PCR (qRT-PCR), and Western blotting (WB). The expression of RvD1 and lipoxin A4/formyl peptide receptor 2 (ALX/FPR2) was assessed by IF and WB. Inflammatory cytokine interleukin (IL) 6 and IL-1β release was measured by ELISA. Results: GO and KEGG analyses indicated that RvD1 regulates the inflammatory process in PDLCs primarily via TLR4-MyD88-mediated NF-κB and MAPK signaling. RvD1 suppressed lipopolysaccharide (LPS)-induced TLR4 and MyD88 expression, inhibited phosphorylation of NF-κB p65 and its inhibitor IKBKB, and attenuated phosphorylation of p38 MAPK, ERK, and JNK. ALX/FPR2 was expressed on hPDLCs and was further upregulated upon treatment with RvD1. RvD1 significantly down-regulated the IL-6 and IL-1β levels in LPS-stimulated hPDLCs. Conclusions: RvD1 regulates the inflammatory response of LPS-stimulated hPDLCs by the TLR4-MyD88-MAPK and TLR4-MyD88-NF-κB signaling pathways, suggesting the potential role of RvD1 in restoring periodontal tissue homeostasis by regulating PDLC response to inflammatory and infectious stimuli.Keywords
Funding Information
- Open Subject Foundation of the Key Laboratory of Dental Maxillofacial Reconstruction and Bio-logical Intelligence Manufacturing (20JR10RA653-ZDKF20210403)
This publication has 71 references indexed in Scilit:
- Evaluation of the anti-inflammatory, antioxidant and regenerative effects of microbiota-derived postbiotics in human periodontal ligament mesenchymal stromal cellsClinical Oral Investigations, 2025
- Resolvin D1 modulates periodontal ligament fibroblast functionJournal of Periodontology, 2022
- Resolvin D1 Attenuates Myocardial Infarction in a Rodent Model with the Participation of the HMGB1 PathwayCardiovascular Drugs and Therapy, 2019
- Resolvin D1 Alleviates the Lung Ischemia Reperfusion Injury via Complement, Immunoglobulin, TLR4, and Inflammatory Factors in RatsInflammation, 2016
- The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritisInflammation Research, 2016
- Development of an immunomodulatory biomaterial: Using resolvin D1 to modulate inflammationBiomaterials, 2015
- Lipoxin A4 modulates adaptive immunity by decreasing memory B‐cell responses via an ALX/FPR2‐dependent mechanismEuropean Journal of Immunology, 2013
- Patterns of Salivary Analytes Provide Diagnostic Capacity for Distinguishing Chronic Adult Periodontitis from HealthJournal of Clinical Immunology, 2012
- Porphyromonas gingivalis-derived lipopolysaccharide-mediated activation of MAPK signaling regulates inflammatory response and differentiation in human periodontal ligament fibroblastsJournal of Microbiology, 2012
- Expression and Genetic Analysis of XIAP-Associated Factor 1 (XAF1) in Cancer Cell LinesGenomics, 2000